Development of [ 225 Ac]Ac PSMA nanodelivery system utilising poly (lactic-co-glycolic) acid-chitosan-folic acid functionalised nanoparticles for targeted alpha therapy of prostate cancer (EANM 2026) - Sep 29, 2026 - Abstract #EPS-221; Pres time: Oct 20, 2026; 04:45 PM - 06:15 PM; Location: Hall G2; "The results of this study indicate that PLGA-Chitosan nanoparticles are a suitable drug delivery vehicle for retaining 225Ac and its daughters at the tumour site, potentially increasing the therapeutic potential of 225Ac-PSMA-617.TFA."
Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|
|
Y. Mzizi 1, 2; B. Witika 3; H. Ndlovu 4; M. Shungube 1; P. Makoni 3; S. Sibiya 1, 2; A. Mdlophane 4; M. Sathekge 1, 2; S. Mdanda 1, 2
|